EP Patent

EP2529774B1 — Resetting mechanism for a drug delivery device

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2022-08-17 · 4y expired

What this patent protects

Patent listed against testosterone-enanthate.

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: EP2529774B1
Jurisdiction: EP
Classification: —
Expires: 2022-08-17
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi Aventis Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.